ArticleCancers2020
Characterization of the DNAM-1, TIGIT and TACTILE Axis on Circulating NK, NKT-Like and T Cell Subsets in Patients with Acute Myeloid Leukemia.
Open access · goldAbstract read
In one paragraph
Article in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.
0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 33 citations in OpenAlex.
- Systemic Immune Correlates of Long-term Survival after Delta-24-RGD Based on the Therapeutic Adenovirus for Recurrent Glioblastoma Effect Trial (TARGET).Clinical cancer research : an official journal of the American Association for Cancer Research · 2026Trial
- Case of complete response to immunotherapy in MMR-deficient prostate cancer associated with NK-like and CD4Cell reports. Medicine · 2026Article
- T cell-engaging bispecific antibodies for myeloid malignancies: Targets, formats, and clinical challenges.Cell reports. Medicine · 2026Review
- Expression of the inhibitory checkpoints LAG-3, TIM-3, and PD-1 in NK cells and T cells in acute myeloid leukemia: preserved expression of LAG-3 is associated with patient survival.Cancer immunology, immunotherapy : CII · 2025Article
- TIGIT antibody with PVR competitive ability enhances cancer immunotherapy and capable of eliciting anti-tumour immune memory.British journal of cancer · 2025Article
- CD155 as a prognostic and predictive biomarker in acute myeloid leukemia.Discover oncology · 2025Article
- TIGIT/PVR axis regulates anti-tumor immunity in hematologic malignancies.Annals of hematology · 2025Review
- A review of common immunotherapy and nano immunotherapy for acute myeloid leukemia.Frontiers in immunology · 2025Review
- Characterization of the Bone Marrow Lymphoid Microenvironment and Discovery of Prognostic Immune-Related Factors in Acute Myeloid Leukemia.International journal of molecular sciences · 2024Article
- The Functional and Prognostic Impact of TIGIT Expression on Bone Marrow NK Cells in Core Binding Factor-Acute Myeloid Leukemia Patients at Diagnosis.Biomedicines · 2024Article
- Immune checkpoint molecule DNAM-1/CD112 axis is a novel target for natural killer-cell therapy in acute myeloid leukemia.Haematologica · 2024Article
- A key to engineering natural killer cells to attack acute myeloid leukemia.Haematologica · 2024Article
- Targeting TIGIT for cancer immunotherapy: recent advances and future directions.Biomarker research · 2024Review
- Exploring NK cell receptor dynamics in paediatric leukaemias: implications for immunotherapy and prognosis.Clinical & translational immunology · 2024Article
- Natural Killer T-like Cells: Immunobiology and Role in Disease.International journal of molecular sciences · 2023Review
- CD96 as a Potential Immune Regulator in Cancers.International journal of molecular sciences · 2023Review
- Enhanced expression of natural cytotoxicity receptors on cytokine-induced memory-like natural killer cells correlates with effector function.Frontiers in immunology · 2023Article
- Acute exercise mobilizes NKT-like cells with a cytotoxic transcriptomic profile but does not augment the potency of cytokine-induced killer (CIK) cells.Frontiers in immunology · 2022Article
- CD96 Downregulation Promotes the Immune Response of CD4 T Cells and Associates with Ankylosing Spondylitis.BioMed research international · 2022Article
- Role of CD155/TIGIT in Digestive Cancers: Promising Cancer Target for Immunotherapy.Frontiers in oncology · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors at 4 institutions in 1 country.
Isabel ValhondoImmunology Unit, University of Extremadura, 10003 Cáceres, Spain.
Fakhri HassounehImmunology Unit, University of Extremadura, 10003 Cáceres, Spain.
Nelson Lopez-SejasImmunology Unit, University of Extremadura, 10003 Cáceres, Spain.
Alejandra PeraDepartment of Immunolgy and Allergy, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), 14004 Cordoba, Spain.ORCID 0000-0003-1169-8996
Beatriz Sanchez-CorreaImmunology Unit, University of Extremadura, 10003 Cáceres, Spain.
Beatriz GuerreroImmunology Unit, University of Extremadura, 10003 Cáceres, Spain.
Juan M BerguaDepartment of Hematology, Hospital San Pedro de Alcantara, 10003 Caceres, Spain.
Maria Jose ArcosDepartment of Hematology, Hospital San Pedro de Alcantara, 10003 Caceres, Spain.
Helena BañasDepartment of Hematology, Hospital San Pedro de Alcantara, 10003 Caceres, Spain.
Ignacio Casas-AvilésDepartment of Hematology, Hospital San Pedro de Alcantara, 10003 Caceres, Spain.
Joaquin Sanchez-GarciaDepartment of Hematology, Reina Sofia University Hospital, 14004 Córdoba, Spain.
Josefina SerranoDepartment of Hematology, Reina Sofia University Hospital, 14004 Córdoba, Spain.
Carmen MartinDepartment of Hematology, Reina Sofia University Hospital, 14004 Córdoba, Spain.
Esther DuranHistology and Pathology Unit, Faculty of Veterinary, University of Extremadura, 10003 Cáceres, Spain.
Corona AlonsoDepartment of Immunolgy and Allergy, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), 14004 Cordoba, Spain.
Rafael SolanaDepartment of Immunolgy and Allergy, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), 14004 Cordoba, Spain.ORCID 0000-0001-8985-0295
Raquel TarazonaImmunology Unit, University of Extremadura, 10003 Cáceres, Spain.ORCID 0000-0002-2926-6377
Universidad de Extremadura · ESHospital San Pedro de Alcántara · ESHospital Universitario Reina Sofía · ESInstituto Maimónides de Investigación Biomédica de Córdoba · ES
Funding
Consejería de Educación y Empleo, Junta de Extremadura TE-00039-18European Regional Development Fund All grants are cofinanced by FEDEREuropean Social Fund TE-00039-18 is cofinanced by FSEInstituto de Salud Carlos III Miguel Servet Type-I contract to APInstituto de Salud Carlos III PI16/01615Junta de Extremadura GR18085Junta de Extremadura IB16164Ministerio de Ciencia e Innovación SAF 2017-87538-R
Abstract
PubMed holds no abstract for this paper.
Indexed as
acute myeloid leukemiaDNAM-1NK cellsNKT-like cellsTACTILET cellsTIGIT
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.